B-Cell Targets to Treat Antibody-Mediated Rejection in Transplantation

Abstract

Abstract: Antibody-mediated rejection (AMR) in allograft transplantation can be defined with a rapid increase in the levels of specific serological parameters after organ transplantation, presence of donor specific antibodies (DSAs) against human leukocyte antigen (HLA) molecules, blood group (ABO) antigens and/or endothelial cell antigens (e.g. MICA, ECA, Vimentin, or ETAR) and also particular histological parameters.

Authors and Affiliations

Keywords

Related Articles

Pharmacological Conditioning of Brain Dead Donor Hearts with Erythropoietin and Glyceryl Trinitrate: Clinical Experience

Background:With the increasing success of heart transplantation, older and higher-risk donors and recipients are being accepted for transplantation. The risk of primary graft dysfunction (PGD) is thus increased. We inves...

Transplantation of Decellularized Venous Valvular Grafts in an Ovine Model

The surgical treatment of end-stage chronic venous insufficiency involves valvular repair or transplantation to restore venous valve function and structure. Current valve substitutes can have issues with durability, thro...

Treatment of Coronary Artery Fistula Post-Cardiac Transplantation with Covered Stent: A Case Study and Review of Literature

The majority of coronary artery fistulas are congenital and discovered incidentally on coronary angiography. Coronary artery fistulas may also develop after cardiac transplantation as a complication of endomyocardial bio...

Sustained In Vivo Perfusion of a Re-Endothelialized Tissue Engineered Porcine Liver

Objective A tissue engineered liver graft will provide a sustainable source of transplantable organs. A porcine liver scaffold was utilized to develop a re-endothelialized revascularized liver capable of sustained in viv...

Distinctive CD8 T Cell Infiltration and Paucity of Regulatory T Cells in Chronic Graft-Versus-Host-Disease Lesions

Alterations in immune reconstitution have been implicated with the development of chronic graft-versus-host disease (cGVHD) in allogeneic bone marrow transplantation (BMT) recipients. Since T cells are important mediator...

Download PDF file
  • EP ID EP343430
  • DOI 10.23937/2572-4045.1510023
  • Views 154
  • Downloads 0

How To Cite

(2016). B-Cell Targets to Treat Antibody-Mediated Rejection in Transplantation. International Journal of Transplantation Research and Medicine, 2(2), 1-2. https://www.europub.co.uk/articles/-A-343430